The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 51.06

+2.3%

Dec 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sun Tzu who wrote (10464)	10/30/2025 7:43:44 PM
From: Sun Tzu	of 10712

IRTC - iRhythm Technologies Stock Climbs on Raised FY Guidance Oct 30, 2025, 18:48 GMT-4Less than 1 min read IRTC-0.63% By Kelly Cloonan Shares of iRhythm Technologies climbed after the company raised its full-year guidance as it sees growing demand for its cardiac monitoring services. The stock rose 14% to $210 on Thursday in after-hours trading. Shares have more than doubled this year through market close. The digital health care company now forecasts revenue of $735 million to $740 million for the year, up from its prior view of $720 million to $730 million. The updated guidance comes after the company narrowed its loss to $5.2 million, or 16 cents a share, from $46.2 million, or $1.48 a share, a year earlier. On an adjusted basis, loss per share was 6 cents. Analysts polled by FactSet expected an adjusted loss of 28 cents. Revenue rose 31% to $192.9 million. Analysts expected $184.8 million. The growth was driven in part by higher demand for cardiac monitoring services within core existing accounts, the company said. Write to Kelly Cloonan at kelly.cloonan@wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next